These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
233 related items for PubMed ID: 21382040
1. The prevalence of human parvovirus B19 DNA and antibodies in blood donors from four Chinese blood centers. Ke L, He M, Li C, Liu Y, Gao L, Yao F, Li J, Bi X, Lv Y, Wang J, Hirsch ML, Li W. Transfusion; 2011 Sep; 51(9):1909-18. PubMed ID: 21382040 [Abstract] [Full Text] [Related]
2. Investigation of the prevalence of human parvovirus B19 DNA in Korean plasmapheresis donors. Oh DJ, Lee YL, Kang JW, Kwon SY, Cho NS. Korean J Lab Med; 2010 Feb; 30(1):58-64. PubMed ID: 20197724 [Abstract] [Full Text] [Related]
4. [Parvovirus B19 among blood donors from three hospitals in Santiago, Chile]. Lévican J, Torres M, Gaggero N, Corvalán R, Gaggero A. Rev Med Chil; 2011 Feb; 139(2):143-9. PubMed ID: 21773649 [Abstract] [Full Text] [Related]
5. [Prevalence of anti-human parvovirus B19 IgG antibody among blood donors in Jilin province]. Wei Q, Li Y, Wang JW, Wang H, Qu JG, Hung T. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2006 Jun; 20(2):60-2. PubMed ID: 16816866 [Abstract] [Full Text] [Related]
7. Effects of transfusion on human erythrovirus B19-susceptible or -infected pediatric recipients in a genotype 3-endemic area. Parsyan A, Addo-Yobo E, Owusu-Ofori S, Akpene H, Sarkodie F, Allain JP. Transfusion; 2006 Sep; 46(9):1593-600. PubMed ID: 16965589 [Abstract] [Full Text] [Related]
11. Prevalence of human erythrovirus B19 DNA in healthy Belgian blood donors and correlation with specific antibodies against structural and non-structural viral proteins. Thomas I, Di Giambattista M, Gérard C, Mathys E, Hougardy V, Latour B, Branckaert T, Laub R. Vox Sang; 2003 May; 84(4):300-7. PubMed ID: 12757504 [Abstract] [Full Text] [Related]
12. Human parvovirus B19: prevalence of viral DNA in volunteer blood donors and clinical outcomes of transfusion recipients. Jordan J, Tiangco B, Kiss J, Koch W. Vox Sang; 1998 May; 75(2):97-102. PubMed ID: 9784661 [Abstract] [Full Text] [Related]
13. Molecular and phylogenetic analyses of human Parvovirus B19 isolated from Brazilian patients with sickle cell disease and β-thalassemia major and healthy blood donors. Slavov SN, Haddad SK, Silva-Pinto AC, Amarilla AA, Alfonso HL, Aquino VH, Covas DT. J Med Virol; 2012 Oct; 84(10):1652-65. PubMed ID: 22930515 [Abstract] [Full Text] [Related]
14. [Research on Parvovirus B19 infections and chronic articular manifestations in a Tunisian hospital]. Regaya F, Khelifa R, Zouari R, Kchir M, Karoui M, Essid R. Arch Inst Pasteur Tunis; 2003 Oct; 80(1-4):9-15. PubMed ID: 15941063 [Abstract] [Full Text] [Related]
15. Recurrent high level parvovirus B19/genotype 2 viremia in a renal transplant recipient analyzed by real-time PCR for simultaneous detection of genotypes 1 to 3. Liefeldt L, Plentz A, Klempa B, Kershaw O, Endres AS, Raab U, Neumayer HH, Meisel H, Modrow S. J Med Virol; 2005 Jan; 75(1):161-9. PubMed ID: 15543575 [Abstract] [Full Text] [Related]
16. Parvovirus B19 transmission by a high-purity factor VIII concentrate. Wu CG, Mason B, Jong J, Erdman D, McKernan L, Oakley M, Soucie M, Evatt B, Yu MY. Transfusion; 2005 Jun; 45(6):1003-10. PubMed ID: 15935000 [Abstract] [Full Text] [Related]
17. Prevalence and genotypic characterization of human parvovirus B19 in children with hemato-oncological disorders in North India. Jain P, Jain A, Prakash S, Khan DN, Singh DD, Kumar A, Moulik NR, Chandra T. J Med Virol; 2015 Feb; 87(2):303-9. PubMed ID: 25087946 [Abstract] [Full Text] [Related]